
USA - New York Stock Exchange - NYSE:IVA.W -
The current stock price of IVA.W is 1.11 null. In the past month the price decreased by -28.39%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
Inventiva S.A. is a clinical-stage biopharmaceutical company. It is focused on the development of oral small molecule therapies for the treatment of NASH, MPS and other diseases with significant unmet medical need. Inventiva S.A. is based in Daix, France.
Ivanhoe Cap Acquisition Corp WT [Ivan/W]
Inventiva S.A. is a clinical-stage biopharmaceutical company. It is focused on the development of oral small molecule therapies for the treatment of NASH, MPS and other diseases with significant unmet medical need. Inventiva S.A. is based in Daix, France.
The current stock price of IVA.W is 1.11 null. The price decreased by -0.89% in the last trading session.
IVA.W does not pay a dividend.
IVA.W has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.